Literature DB >> 15790353

CTLA4 gene polymorphism and autoimmunity.

Stephen C L Gough1, Lucy S K Walker, David M Sansom.   

Abstract

CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA4) are two receptors that have critical but opposing functions in T-cell stimulation. CD28 promotes a number of T-cell activities, whereas in contrast CTLA4 is an essential inhibitor of T-cell responses. Because of its inhibitory role, CTLA4 is a strong candidate susceptibility gene in autoimmunity and several studies suggest disease-associated polymorphisms. In this review, we discuss recent progress in relating CTLA4 polymorphisms to disease susceptibility and consider the putative mechanisms by which CTLA4 may act to inhibit autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15790353     DOI: 10.1111/j.0105-2896.2005.00249.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  105 in total

1.  Genetics of thyroid function and disease.

Authors:  Vijay Panicker
Journal:  Clin Biochem Rev       Date:  2011-11

Review 2.  Co-stimulatory blockade as therapy for rheumatoid arthritis.

Authors:  Sarah L Mackie; Edward M Vital; Frederique Ponchel; Paul Emery
Journal:  Curr Rheumatol Rep       Date:  2005-10       Impact factor: 4.592

3.  Genetic variants in T helper cell type 1, 2 and 3 pathways and gastric cancer risk in a Polish population.

Authors:  Rajeev Mahajan; Emad M El-Omar; Jolanta Lissowska; Paolo Grillo; Charles S Rabkin; Andrea Baccarelli; Meredith Yeager; Leslie H Sobin; Witold Zatonski; Stephen J Channock; Wong-Ho Chow; Lifang Hou
Journal:  Jpn J Clin Oncol       Date:  2008-08-07       Impact factor: 3.019

Review 4.  Genetics and genomics of primary biliary cirrhosis.

Authors:  Brian D Juran; Konstantinos N Lazaridis
Journal:  Clin Liver Dis       Date:  2008-05       Impact factor: 6.126

5.  Association of CTLA4, CD28 and ICOS gene polymorphisms with clinicopathologic characteristics of childhood IgA nephropathy in Korean population.

Authors:  Hak-Jae Kim; Joo-Ho Chung; Sungwook Kang; Su-Kang Kim; Byoung-Soo Cho; Sung-Do Kim; Won-Ho Hahn
Journal:  J Genet       Date:  2011-04       Impact factor: 1.166

Review 6.  Checkpoint Inhibitors: Applications for Autoimmunity.

Authors:  Anna S Tocheva; Adam Mor
Journal:  Curr Allergy Asthma Rep       Date:  2017-09-27       Impact factor: 4.806

7.  CTLA4 and generalized vitiligo: two genetic association studies and a meta-analysis of published data.

Authors:  Stanca A Birlea; Greggory S Laberge; Lucia M Procopciuc; Pamela R Fain; Richard A Spritz
Journal:  Pigment Cell Melanoma Res       Date:  2009-01-17       Impact factor: 4.693

8.  Hypophysitis Secondary to Cytotoxic T-Lymphocyte-Associated Protein 4 Blockade: Insights into Pathogenesis from an Autopsy Series.

Authors:  Patrizio Caturegli; Giulia Di Dalmazi; Martina Lombardi; Federica Grosso; H Benjamin Larman; Tatianna Larman; Giacomo Taverna; Mirco Cosottini; Isabella Lupi
Journal:  Am J Pathol       Date:  2016-10-15       Impact factor: 4.307

9.  Variation in the CTLA4 3'UTR has phenotypic consequences for autoreactive T cells and associates with genetic risk for type 1 diabetes.

Authors:  V M de Jong; A Zaldumbide; A R van der Slik; S Laban; B P C Koeleman; B O Roep
Journal:  Genes Immun       Date:  2015-12-10       Impact factor: 2.676

10.  Analysis of single nucleotide polymorphisms in the FAS and CTLA-4 genes of peripheral T-cell lymphomas.

Authors:  Irina Bonzheim; Eva Geissinger; Wen-Yu Chuang; Sabine Roth; Philipp Ströbel; Alexander Marx; Peter Reimer; Martin Wilhelm; Bernhard Puppe; Andreas Rosenwald; Hans Konrad Müller-Hermelink; Thomas Rüdiger
Journal:  J Hematop       Date:  2008-04-24       Impact factor: 0.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.